- Home
- IGMS vs LESL Comparison
IGMS vs LESL Comparison
Compare IGMS & LESL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGMS
- LESL
- Stock Information
- Founded
- IGMS 1993
- LESL 1963
- Country
- IGMS United States
- LESL United States
- Employees
- IGMS N/A
- LESL N/A
- Industry
- IGMS Biotechnology: Pharmaceutical Preparations
- LESL Diversified Commercial Services
- Sector
- IGMS Health Care
- LESL Miscellaneous
- Exchange
- IGMS Nasdaq
- LESL Nasdaq
- Market Cap
- IGMS 82.1M
- LESL 90.5M
- IPO Year
- IGMS 2019
- LESL 2020
- Fundamental
- Price
- IGMS $1.36
- LESL $0.42
- Analyst Decision
- IGMS Hold
- LESL Hold
- Analyst Count
- IGMS 8
- LESL 11
- Target Price
- IGMS $6.00
- LESL $2.12
- AVG Volume (30 Days)
- IGMS 1.1M
- LESL 5.3M
- Earning Date
- IGMS 08-13-2025
- LESL 08-06-2025
- Dividend Yield
- IGMS N/A
- LESL N/A
- EPS Growth
- IGMS N/A
- LESL N/A
- EPS
- IGMS N/A
- LESL N/A
- Revenue
- IGMS $2,681,000.00
- LESL $1,319,859,000.00
- Revenue This Year
- IGMS $134.30
- LESL $1.64
- Revenue Next Year
- IGMS $22.37
- LESL $2.74
- P/E Ratio
- IGMS N/A
- LESL N/A
- Revenue Growth
- IGMS 27.36
- LESL N/A
- 52 Week Low
- IGMS $0.92
- LESL $0.40
- 52 Week High
- IGMS $22.50
- LESL $4.22
- Technical
- Relative Strength Index (RSI)
- IGMS 59.58
- LESL 30.49
- Support Level
- IGMS $1.12
- LESL $0.40
- Resistance Level
- IGMS $1.39
- LESL $0.46
- Average True Range (ATR)
- IGMS 0.08
- LESL 0.06
- MACD
- IGMS 0.01
- LESL -0.00
- Stochastic Oscillator
- IGMS 83.87
- LESL 9.50
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.